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1. Introduction 
The number of women in the USA with breast implants is now estimated at over 6 million 
based on national surveys. This is numerically in excess of 5% of the female adult 
population. The majority of these women had cosmetic augmentations but 20-30% had 
implant based post-mastectomy breast reconstructions or correction of congenital 
abnormalities. In 2010, 296203 breast augmentations were performed in the USA and 
silicone implants were used in 60% of cases (American Society of Plastic Surgeons [ASPS], 
2010). 93083 breast reconstructions were performed for congenital or postmastectomy 
defects. Of these 67% were performed using tissue expander and implant techniques. The 
significant majority of implants used in breast reconstruction were silicone (73%). 
Reconstructions using autologous tissue formed a small percentage of overall 
reconstructions (transverse rectus abdominus myocutaneous flaps (TRAM) 7%, latissimus 
dorsi (LD) flaps 7% and deep inferior epigastric perforator flaps (DIEP) 5%). 
 
Table 1. Breakdown of breast reconstruction procedures performed in 2010 according to 
procedure type and age range (ASPS, Report of the 2010 Plastic Surgery Statistics) 
The history of implant based breast reconstruction spans five decades when the first silicone 
breast implants became available. The last 20 years have seen rapid advances in expander 
and implant technology such that the era in which implant reconstructions aimed at simply 
producing the appearance of a breast mound in clothing has transitioned into the current 
era in which in appropriately selected patients an implant based reconstruction has the 
potential to resemble a natural breast in contour, projection and a well-defined 
inframammary crease.  
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A common misconception is that breast reconstructions with autologous tissue are 
necessarily superior in quality compared to reconstructions with implants. Patient selection 
and a full discussion on rewards versus risks enable patient choice in making an informed 
decision about the reconstructive options available. The longer complex procedures to 
harvest autologous donor material, often involving microvascular surgery, are associated 
with donor site healing and scars with a longer period of recovery compared with implant 
based breast reconstruction. Excellent outcomes can be achieved with implant based 
reconstruction, optimising the implant pocket where necessary with staged surgery, 
acellular dermal matrices, fat transfer techniques but with the more likely need for 
maintenance surgery in the longer term. Breast reconstruction surgery is a process and often 
involves secondary procedures, whether the primary reconstruction is autologous or 
implant based. 
Implant based breast reconstruction is technically challenging and great care and attention 
to detail is necessary to achieve the best results. With autologous breast reconstruction, if 
sufficient amounts of skin and fat can be brought to the site of the mastectomy, it is 
relatively simple to shape this tissue to achieve an attractive result with the breast 
reconstruction. Implant based breast reconstruction requires careful assessment to 
determine suitability for one-stage or two-stage surgery; fixed volume, expandable implants 
or tissue expanders; shaped or round devices; pocket enhancement techniques or the 
incorporation of implant plus autologous tissue flaps. The process can be a complex 
algorithm based on multifactorial parameters that may be patient and surgeon dependent.  
The backbone of two-stage implant based reconstructions is tissue expansion. The 
placement of an expander can be performed in either an immediate or delayed setting 
following mastectomy for breast cancer. Tissue expansion is often a pre-requisite in the 
delayed setting while a choice of tissue expansion, the insertion of a permanent fixed 
volume or expandable implant is available in the immediate setting. Immediate 
reconstructions have the advantage that patients wake up from surgery with a reconstructed 
breast, limiting some of the psychological sequelae experienced by patients following 
mastectomy. This is of particular relevance in patients undergoing risk reducing surgery 
who are usually young women undergoing bilateral procedures who should not require 
adjuvant therapy and would desire a rapid return to normal life. However, there are some 
advantages to delaying reconstruction in an oncologic setting. The delayed insertion of a 
tissue expander is less technically challenging. As the post-mastectomy skin-flaps have been 
allowed time to heal, there is a reduced risk of skin flap ischaemia and wound healing 
complications. Delaying reconstruction also eliminates the uncertainty of postoperative 
chest wall radiotherapy and allows more flexibility with operating theatre scheduling. 
Returning to surgery for the implant exchange allows pocket revision to optimise the 
reconstructed breast form. 
Initial expander and implant devices were rudimentary and cosmetic outcomes were 
limited. These early devices had smooth elastomer surfaces and were associated with high 
rates of capsular contracture and device displacement. Aesthetic outcome was less 
predictable and in many cases, it was necessary to perform multiple adjustments to improve 
implant position, projection, or inframammary fold definition. In other cases, patients were 
expected to live with reconstructions that simply produced the impression of a breast 
mound in clothing. The unpredictability and inconsistency of expander-implant 
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reconstructions drove the development of alternative strategies to reconstruct the breast, 
namely autologous tissue options (initially the TRAM and LD flaps, and later the DIEP 
flaps), initially as replacements or salvage techniques and later as the primary approach to 
breast reconstruction. Autologous tissue reconstructions have become popular with some 
surgeons as a satisfactory breast mound can usually be achieved in a single operative 
procedure with more predictable long-term results and lower complication rates when 
compared with tissue expansion and implant techniques (Beasley &Ballard, 1990; Rosen et 
al., 1990). It is possible to combine tissue expansion with autologous tissue flap procedures, 
although an often cited advantage of autologous reconstruction is to avoid the 
disadvantages associated with the use of an implant. The main advantages that expander-
implant reconstructions have over autologous muscle flap techniques include the shorter 
surgical time and quicker recovery, avoiding the use of donor tissue and associated donor 
site morbidity with relatively short scars to complement the minimal access approach of 
skin-sparing mastectomy. The need for secondary procedures to refine the reconstructed 
breast, the contralateral breast or the trunk is common to all reconstruction types. Several 
generations of silicone implants have been developed since 1963, with a gradual progression 
to improved surface texturing, gel consistencies, range of sizes and shapes. The availability 
of these newer and improved devices has enabled surgeons to obtain more consistent and 
aesthetically pleasing results. Within the limitations of each individual’s chest wall anatomy, 
soft tissue characteristics and opposite breast contour, a realistic implant based breast 
reconstruction is now achievable. 
2. Types of implants 
2.1 Silicone 
Silicone refers to a group of polymers, based on the element silicon. Silicon dioxide (sand) is 
one of the most abundant compounds on Earth. The silicone polymer polydimethylsiloxane 
(PDMS) is abundantly used in medical applications from indwelling catheters, extended 
wear contact lenses, pacemakers, syringes and pharmaceuticals to name but a few. Silicone 
is ideally suited for medical use because of its thermal and oxidative stability, chemical and 
biological inertness, hydrophobic nature and sterilization capability. Silicone polymers may 
be produced in a variety of forms, including oil, gels or elastomers (rubber). The physical 
state is determined by the degree of chemical cross-linking. Cross-linking occurs between 
vinyl and hydrogen groups on silicon atoms. Silicone oils are straight chains of PDMS 
without cross-linking and are insoluble in water. Silicon gels consist of cross-linked PDMS 
chains, together with variable amounts of PDMS liquid. Elastomers of silicone have high 
degrees of cross-linking and almost no PDMS oil. Common to all implants is the outer shell 
made out of silicone elastomer reinforced with silica. The shell can be single or double 
layered, smooth or textured, barrier coated and/or covered with polyurethane foam.  
2.1.1 A short history of silicone implants 
The modern silicone breast implant as we know it was released to the open market in 1963. 
It has gone through intense phases of development which have improved the initially 
primitive and limited devices to current day devices which exhibit a tremendous range of 
surface textures, sizes, gel consistencies and anatomical shapes.  
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2.1.2 First generation (1960s) 
The original silicone gel implant was developed by Cronin and Gerow and was named the 
Silastic 0. These implants had envelops of thick smooth walled silicone elastomer made in 2 
sections and filled with viscous silicone gel material. The shell halves were then glued 
together. By the end of the 1960s the shell was cast as a single unit and sealed with a small 
patch. Fixation patches were introduced in the early part of this period because it was felt 
that scar and tissue ingrowth was necessary to fix the implant and prevent migration. These 
fixation patches were made out of Dacron mesh, perforated silicone or polyurethane foam. 
Not only were the patches found to be generally unnecessary, they also increased the 
rupture rate by creating stress points in the envelope.  
2.1.3 Second generation (1970s) 
A new generation of thinner shells and less viscous gels were released in the mid-1970s as 
attempts to reduce capsular contractures. Unfortunately not only were capsular contracture 
rates unchanged, these fragile devices were more prone to rupture.  
2.1.4 Third generation (1980s) 
This period saw significant advances in silicone technology and the implants produced 
during this era form the backbone of our current devices. Stronger shells reduced the 
amount of silicone oil “bleed” into adjacent tissues. The gel content was made more viscous 
and cohesive. Expandable implants with subcutaneous ports were also developed. In 1989 
textured-surface envelopes became available. These were felt to reduce capsular contracture 
rates. Polyurethane coating of implants was first introduced in the 1960s but did not gain 
popularity until the 1980s. The reduction in capsular contracture seen with polyurethane 
coated devices was attributed to its open cell structure which allowed tissue in-growth and 
prevented a regular circumferential deposition of collagen. 
In the early 1990s the modern silicone implant was affected by a substantial negative media 
publicity campaign over the apparent danger of breast implants resulting in a marked drop in 
the use of silicone implants for all indications. Safety issues centred around silicone oil leakage 
locally and systemically and the use of polyurethane coating that had become popular towards 
the end of 1980s. Polyurethane was shown to undergo a degradation process in vivo that 
produced toluenediamine (TDA). This chemical was a known carcinogen in rats. At that time, 
the risk to humans was unknown but has been since shown to be extremely low. Further, the 
polyurethane coating was found to completely delaminate from the underlying silicone shell 
after several years in vivo. This resulted in loss of implant form. The devices were voluntarily 
removed from the market in the early 1990s. There has since been extensive research proving 
the safety of silicone and breast implants. Evidence is widely available disproving any 
correlation between implants (or silicone) and carcinogenesis, delayed cancer detection, 
autoimmune disease, neurological disease, teratogenecity and TDA toxicity. 
2.1.5 Fourth and fifth generation implants 
The adverse publicity seen in the 1990s resulted in stricter manufacturing standards. 
Current implants of the fourth and fifth generations are essentially refined 3rd generation 
devices. These devices include cohesive gel products in which, instead of cross linkage of 
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only 20% of gel contents (and therefore the remaining 80% being oil), the cross linking is 
40% of the contents. The resulting gel is much stiffer and maintains its shape even when cut 
therefore controlling spread of gel contents in the event of shell rupture. Larger incisions are 
however required to accommodate these less flexible implants. In an effort to reduce gel 
bleed from silicone-filled devices, phenyl or triflouropropyl groups are bonded to the shell 
to decrease the shell permeability to PDMS oil. These low bleed implant shells with barrier 
coating are characteristic of current third, fourth and fifth generation implants. 
2.2 Saline 
These devices are inserted empty and are filled with saline at surgery. Each size has a 
recommended fill range provided by the manufacturer. Overfilling produces a firm device 
and under filling risks early rupture from a process called “fold flaw” which results in 
increased rubbing of the membrane at that point. Any breach of the shell results in instant 
deflation and harmless absorption of the saline over the next day or two. 
2.3 Textured versus smooth surfacing 
There are several commercially manufactured varieties of textured silicone elastomer shells. 
Mentor have developed the Siltex pattern which results as a negative contact imprint of a 
texturing foam This process produces many fine nodules on the surface of the shell in a 
regular distribution. Allergan’s Biocell surface is produced through a lost salt technique. The 
implant shell is coated with finely graded salt under light pressure. The salt crystals are 
subsequently lost through the manufacturing process, leaving many fine depressions on the 
surface of the shell. True tissue in-growth with textured surfaces only occurs reliably when 
the implant is placed in a snug pocket or in the tissue expansion environment. These 
textured surfaces may reduce the rate of capsular contracture but this effect has only been 
seen in silicone implants and not in saline filled devices. Texturing to provide adhesion of 
the implant to the surrounding tissue is an important consideration with shaped devices to 
prevent rotation but may impact negatively on implant scalloping of the overlying skin. 
2.4 Expandable implants 
Permanent expandable implants combine an outer chamber of factory prefilled silicone with 
an inner chamber that allows post-operative filling with saline. In current practice the 2 
relevant implant valve types are the Becker self-sealing valve which closes on removal of the 
filling tube and port and the Allergan 150 valve which is plugged when the fill tube is 
removed. These implants permit gradual and temporary over inflation to create an ample 
pocket and then can be left in as a permanent implant after the size has been adjusted 
satisfactorily.  
2.5 Shaped versus round implants 
Implants can be either shaped or round. Shaped implants can also be referred to as tear 
dropped, contoured or anatomical. Shaped implants have greater fullness in the lower half 
and less fullness in the upper half. Some surgeons feel that these implants provide a more 
natural breast shape particularly in women with extremely little or no breast tissue as these 
women would appear too full in the upper pole if a round implant was inserted. Others feel 
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that the shaped implant makes no difference to the final result and compensate for upper 
pole fullness in small breasted women by lowering the position of the implant. Further, 
because the silicone gel or saline component of the round implant gravitates to the lower 
pole of the implant when a woman stands, the lower pole naturally becomes fuller, and 
some argue that this negates the need for a shaped implant. The disadvantage of shaped 
implants is that post-surgery rotation would result in an obvious sideways appearance to 
the breast requiring revisional surgery, a problem that does not arise with a round implant. 
In order to reduce the risk of rotation, shaped implants are textured to reduce the risk of 
rotation. Shaped implants are generally more expensive than rounded implants.  
3. Patient selection 
Important factors that should be considered during the patient selection process include 
patient features (breast volume, breast shape, the contralateral breast, chest wall, body mass 
index, lifestyle including work and sport, and co-morbid factors), patient understanding (of 
the procedure, complications, implications and of the device), and the oncologic features (skin 
sparing mastectomy versus traditional mastectomy, systemic therapy needs and adjuvant 
radiotherapy). Conventional teaching stipulates that the ideal woman for an implant based 
reconstruction has small to moderate sized breasts without significant ptosis. Bilateral breast 
reconstructions for cancer or risk reduction may also be ideal because it provides an optimum 
scenario for achieving symmetry. Patients undergoing unilateral mastectomies may require a 
contralateral procedure for symmetrisation by augmentation, mastopexy or breast reduction. 
Women who rely on upper limb strength for work or sport may be directed towards an 
implant reconstruction or muscle sparing autologous abdominal option as this would avoid 
the potential functional morbidity experienced that may follow an LD flap reconstruction. 
Women with large or ptotic breasts may still be suitable for implant reconstruction by 
utilization of a skin-sparing volume reducing approach. A Wise pattern approach allows 
reduction of the skin envelope. The de-epithelialized lower flap facilitates lower pole implant 
cover and often allows for pseudo-ptosis with careful positioning of the inframammary crease. 
The nipple may be preserved on the superior mastectomy skin flap. Caution may need to be 
exercised in women with a generous subcutaneous adipose covering as implant projection 
may be compromised by the depth of the rib cage below the fat layer.  
There are relative contraindications which would make some patients less suited to an 
implant based reconstruction. Aside from the usual medical conditions that would increase 
the risk of anaesthesia or infection, a significant contraindication is unrealistic expectation. 
Patients with large or advanced breast cancers and clinically involved axillary lymph nodes 
are likely to require adjuvant radiotherapy. Radiotherapy either prior to implant insertion or 
following implant insertion can result in hardened and thickened soft tissues and initiate or 
exacerbate capsular contraction.  
4. Preparing a patient for an implant breast reconstruction 
4.1 Biodimensional planning 
Biodimensional planning involves taking a few detailed chest measurements, including the 
sternal-notch nipple, inframammary crease nipple and midline nipple distances. The 
attributes of the existing breast form should be measured, namely the transverse breast 
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width, vertical breast height and projection. These measurements along with pre-operative 
photographs form an essential part of the medical records of the pre-operative state on 
which post-operative evaluation can be compared. Careful assessment should be made of 
the patient’s chest wall, general predisposition and soft tissue properties.  
 
  
Implant reconstruction Autologous reconstruction 
Anatomy and 
patient 
physique 
Small to moderate sized breasts with minimal 
ptosis are best suited for implant reconstruction 
Implant reconstruction for large, ptotic breasts can 
still be achieved by performing a Wise-pattern skin-
sparing volume reducing mastectomy  
Body habitus/BMI: excessive subcutaneous 
adiposity risks compromising implant projection  
Larger, ptotic breasts may be 
better reconstructed using 
autologous tissue 
Attitude and 
anxieties 
Patient wants a shorter procedure with a more 
rapid post-operative recovery period 
 
 
Does not mind the presence of a device 
Patient is willing to invest 
time and effort in a longer 
and more complex operation 
 
Can accept the additional 
potential complications 
associated with the donor 
site 
Does not want reconstruction 
using a device
Stage of 
disease 
Earlier disease with a lesser chance of adjuvant 
chest wall radiotherapy with its associated 
increased risk of capsulation 
 
 
 
A temporizing implant can be used to maintain the 
skin envelope. This can be deflated if radiotherapy 
is required to optimize delivery of external beam 
therapy. If radiotherapy is not required, prompt 
implant exchange can be performed to avoid delay 
to other adjuvant therapies
More advanced disease with 
a higher chance to chest wall 
radiotherapy becoming 
necessary.  
 
Radiotherapy will still affect 
autologous tissues but 
capsulation is avoided 
General 
health 
A patient who would benefit from a shorter 
operation and more rapid post-operative recovery 
period i.e. a person with a greater number of 
comorbidities and is at higher anaesthetic risk
Low anaesthetic risk 
Muscle 
function 
Relies on upper limb function for work or sport and 
therefore should avoid a latissimus dorsi flap. 
 
Increased use of abdominal wall in sport or work, 
may be at higher risk of abdominal wall herniation 
if TRAM is performed
Loss of muscle function or 
effect of long scars should 
not have profound effect on 
work, activities of daily 
living or sport 
Bilateral 
procedures 
Ideally suited to implant reconstructions as 
provides the greatest opportunity to achieve 
symmetry 
Increases the complication 
and anaesthetic risks 
associated with these longer 
and more complex 
procedures
Table 2. Description of patient characteristics that may influence the type of breast 
reconstruction chosen 
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Fig. 1. Measurement of the existing breast form are taken as part of biodimensional planning 
These factors contribute to the choice of surgical technique and aid implant selection so that 
the optimum breast reconstruction is achieved for that individual. Both round and shaped 
implants are available in a range of base widths, heights and profiles. The main determinant 
of implant selection is breast width. This takes account of the patient’s chest wall 
characteristics and is an essential consideration in order to avoid placing a narrow implant 
on a wide chest wall or conversely a wide implant on a narrow chest wall. Once the base 
width is established the appropriate height can be selected. Patients who have less ptosis 
will have a fuller upper pole and would therefore benefit from a rounded implant or taller 
height implant whereas a more ptotic breast would be better reconstructed using a shaped 
implant with a shorter height. The profile refers to the amount of forward projection of the 
implant from the chest wall and range from low to ultra-high projections. Profile selection 
can be guided by comparison to the contralateral breast or by patient’s desire for projection, 
adjusting the contralateral breast as appropriate. In patients with extremely wide chest walls 
and excessive subcutaneous tissue, achieving adequate projection is a challenge and these 
patients are therefore less suited to an implant only reconstruction. 
4.2 Marking up 
With the patient sitting or standing up, the midline, the breast meridian, inframammary 
folds, lateral border and upper extents of both breasts should be marked. The breast 
meridian can be taken from a point 5cm lateral to the medial end of the clavicle to the centre 
of the nipple and the line extended to the inframammary crease. Mark the meridian beyond 
the inframammary crease as the marking often washes out during the surgery. The skin 
incision should also be indicated. In many cases of immediate breast reconstruction, a skin-
sparing approach is suitable but may sometimes need to be modified to take into account 
pre-existing scars. The choice of skin incision is extremely variable and dependent on each 
individual case and the surgeon’s preference. Common skin incisions include the 
circumareolar incision, circumarealor incision with a lateral or vertical extension and the 
inframammary fold incision. It is best to avoid extending the incision into the superior and 
medial sectors of the breast. The incision should be planned to allow preservation of the 
most favourable blood supply to the mastectomy skin flaps. 
If skin excision is to form part of the mastectomy, commonly used patterns include the 
circumareolar to excise the nipple areolar complex with a range of extensions, most commonly 
lateral or vertical. The nipple areolar complex could also be incorporated into a number of skin 
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excision patterns including the oblique ellipse, transverse ellipse, vertical ellipse, inverted T 
shape, mastopexy and Wise pattern excisions. This wide variation could also be modified for 
nipple preservation in suitable cases. Ultimately the goal is to leave sufficient amounts of well-
vascularized skin while excising the maximum amount of breast tissue.  
 
Fig. 2. Classification of skin sparing mastectomy (Carlson, 1997)  
Good cover of the implant or the tissue expander should be obtained such that the desired 
breast shape is created without undue laxity or tension and without skin necrosis from 
ischaemic flaps. When the plan for reconstruction includes the addition of a flap, the 
surgical excision can be designed such that the planned skin paddle of the transposed 
myocutaneous flap accurately replaces the area of removed native breast skin. 
  
Fig. 3. An implant assisted LD breast reconstruction following a skin sparing mastectomy. 
The planned skin paddle of the LD flap accurately replaces the removed nipple-areolar complex 
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4.3 Positioning 
Most surgeons would perform the mastectomy on a supine patient with both arms out on a 
board to add access to the lateral extent of the breast incision, to allow access to the axillary 
nodes and to enable comparison with the contralateral breast. Adequate exposure should be 
provided when draping the patient to view the collar bones, lateral extents of both breasts 
and the lower chest. Creation of the submuscular pocket, reshaping of the mastectomy space 
and device insertion can be done with the patient supine initially, and the patient can be 
moved into a sitting position intra-operatively to allow for positional variation. Further 
adjustments to the pocket can then be performed. These stages of the breast reconstruction 
can be performed on patients at 45 degrees or in a complete upright sitting position. 
Appropriate operating table choice and positioning is essential prior to draping. 
5. Reconstruction options 
5.1 Immediate reconstruction 
The options for immediate implant based reconstruction are as follows: 
 One stage using a permanent implant 
 One stage using an expandable implant  
 Two stage using a tissue expander and subsequent implant exchange 
The replacement of mammary tissue with an implant immediately after a mastectomy has 
been refined over the years and usually implies the use of an expandable implant as a 
planned one stage procedure or the insertion of a tissue expander prior to the subsequent 
placement of a permanent fixed volume implant. Occasionally an adequate submuscular 
pocket can be created for a fixed volume implant at the primary procedure. Unless oncologic 
criteria determine otherwise, a skin-sparing mastectomy is commonly performed in 
association with an immediate breast reconstruction. 
5.1.1 Implant reconstruction in small breasts with minimal ptosis 
This forms the classic group of patients in whom implant based breast reconstruction is 
often described. Tissue expansion can usually be avoided in patients with small breasts who 
require reconstruction of a non-ptotic breast of similar or slightly larger size. In such 
patients, an increase in the desired reconstructed breast size usually requires the use of an 
expandable implant as a planned one stage procedure in the presence of an adequate 
pocket. A significant increase in size is best addressed as a two stage procedure. If nipple 
preservation is being considered, this can usually be maintained attached to the mastectomy 
flap via the periareolar extension, with or without extensions for access.  
5.1.2 Implant reconstruction in moderate sized breasts 
The place of implant breast reconstruction in this patient is also established. For women 
with moderate sized breasts and no or minimal ptosis, total submusculo-fascial cover may 
not be achieved and it is not the authors’ preference to have incomplete implant cover. Such 
cases may be best addressed as a two stage tissue expansion procedure, inserting a tissue 
expander into the submusculo-fascial pocket and expanding over an interval in outpatients, 
before a two stage implant exchange. 
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The use of acellular dermal matrices (vide infra) has extended the role of one stage implant 
reconstruction in this group of patients. An implant assisted latissimus flap also provides for 
excellent long term implant cover in this patient group. The acceptance of nipple 
preservation in some patient subgroups in conjunction with use of an acellular dermal 
matrix has renewed interest in the inframammary crease approach, preserving the nipple in 
its normal anatomical position and draping the lower pole of the retained skin envelope 
over the acellular dermal matrix sheet interpositioned between the lower freed border of 
pectoralis major and the surgically created inframammary crease. Nipple preservation if 
appropriate can also be maintained via the periareolar incision with or without extension for 
access. The larger the increase in size from the original breast envelope the more 
unpredictable the final nipple position on the reconstructed breast. Great care needs to be 
taken in surgical planning to maintain the nipple position at the appropriate height in the 
breast meridian that needs to coincide with the projected new midline nipple distance, that 
requires to match the contralateral side. 
5.1.3 Implant reconstruction in women with larger breasts 
In women with larger and ptotic breasts, the use of a Wise pattern approach provides 
excellent access to perform a mastectomy despite the breast size. The lower mastectomy-
skin flap is de-epithelialized and used to provide lower pole implant cover. This approach 
usually results in a smaller breast mound that corrects for ptosis and is considered a skin-
sparing volume reducing technique. The implant reconstruction can usually be performed 
with a fixed volume device or expandable implant as a one stage procedure. Planning a two 
stage procedure has some advantages of returning to optimize the pocket but may not be an 
essential second step as excellent pocket control can be achieved with this surgery. The 
procedure is well suited to bilateral cases and in unilateral cases, the contralateral breast will 
require a reduction mammaplasty for symmetry. Nipple preservation is possible with this 
technique if oncologic parameters allow, usually based on the superior skin flap. The ability 
to use the de-epithelialized lower flap often negates the requirement for an acellular dermal 
matrix in this type of operation. 
5.2 Skin sparing mastectomy 
Many access incisions for skin-sparing mastectomy have been described. Fiberoptic lighting 
or headlamps are very useful to visualize dissection through minimal access incisions. Great 
care must be taken to avoid trauma by distension and diathermy injury to the skin flaps. 
Insulated instruments are helpful when diathermy dissection is used. After mastectomy, 
careful haemostasis is essential.  
If the nipple is to be preserved, intra-operative frozen sections of the nipple base or nipple 
core to confirm a clear nipple margin of resection can be helpful. Histologically proven 
cancer extension into the nipple zone at the time of surgery is best treated by primary nipple 
resection. Preservation of the areola at nipple resection may be one option (Simmons, 2003). 
Delayed identification of nipple involvement when standard histological assessment is back 
may pose a dilemma on further management. The option of targeted radiotherapy may have 
a role and may be an alternative to the more common recommendation of secondary nipple 
excision.  
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Fig. 4. Examples of skin incisions. A, transverse incisions. B, verticle incision. C, wise pattern 
excision without nipple preservation. D, peri-areolar incisions with lateral extension 
 
Fig. 5. Wise pattern skin excision for nipple sparing mastectomy. A, skin excision is 
performed and the marked areas are de-epithelialised. B, The de-epithelialised lower flap is 
disconnected and sutured to the inferior edge of pectoralis. C, The upper flap is drapped 
over the implant and the de-epithelialized lower flap. A butterfly needle has been inserted 
into the laterally sited injection port to allow adjustments to final inflation volume of the 
permanent expandable implant during pocket and skin closure. D, The incisions are closed 
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5.3 Creating the submuscular pocket 
5.3.1 Raising pectoralis major 
Following completion of the mastectomy, attention is turned to creation of a submuscular or 
submusculo-fascial pocket to house the implant or expander. To create a space in the 
submuscular plane, the fibres of pectoralis major are split 1cm lateral to the free lateral 
border. The inferior surface of pectoralis major is raised off the rib cage and the dissection 
taken medially taking care to preserve the anterior intercostal perforators as they emerge 
through the intercostal spaces close to the lateral sternal edge. The pectoralis major muscle 
should not be detached from the sternum. The upper border is taken to 1cm beyond the 
marked upper pole of the projected breast mound to ensure a gentle take off of the superior 
reconstructed breast. The inferior musculo-fascial border is created by disconnecting the 
attachment of pectoralis major to the ribcage from within the pocket. This takes the 
dissection on to a plane in continuity with the anterior rectus sheath, allowing the lower 
pole of the breast reconstruction to rise on the inferior implant surface. This dissection needs 
to be limited by the marking of the existing or new inframammary crease. Sparing the 
contents of the inframammary fold facilitates this dissection and avoids buttonholing of the 
thin fascia that can exist below the fibres of the pectoralis attachment. 
 
Fig. 6. Skin sparing mastectomy through a transverse incision. A, open pocket with implant 
visible. A butterfly needle has been inserted into the subcutaneous injection port laterally to 
allow adjustments to final inflation volume of the permanent expandable implant during 
pocket closure. B. Closed muscular pocket with the sutured edge of pectoralis major visible, 
the lateral border attached to serratus anterior 
5.3.2 Providing cover for the inferior mammary space 
When the inferior mammary musculo-fascial space does not provide adequate cover, the 
disconnected inferior border of pectoralis major may either be attached to the lower 
mastectomy flap by a series of interrupted sutures or alternatively holding sutures to the 
tough fascia of the inframammary crease like guide ropes, allowing the anterior surface of 
the muscle to adhere to the mastectomy skin flaps. In this situation, a two staged planned 
implant exchange is usually the preferred option enabling a return to optimise the implant 
pocket at a subsequent procedure. The development of acellular dermal matrices has made 
cover of the lower implant pole in this circumstance much simpler and interposition of a 
matrix sheet cut to size to interposition the required space between the free muscle border 
and the inframammary crease feasible as a one stage procedure. 
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5.3.3 The lateral pocket 
The lateral musculo-fascial pocket is created by dissecting down from the lateral edge of the 
split pectoralis major fibres on to the lateral chest wall to find the anterior fibres of serratus 
anterior as they attach to the rib cage. Often this involves dividing some of the fibres at the 
lateral edge of pectoralis minor. The serratus anterior fibres can be freed to a varying extent 
to house the expander or implant. In general, in a planned two stage expansion, this 
dissection laterally can be limited to fit the footprint of the device, the true expansion 
process occurring post-surgery as an outpatient. In a planned one stage reconstruction, the 
dissection may need to be taken far back enough to free the anterior rib cage attachment of 
the serratus anterior to allow the lateral pocket to be raised fully to cover the fixed volume 
or expandable implant. Anatomically this extended lateral pocket consists of the lateral 
fibres of pectoralis major, the intervening fascia between pectoralis major and serratus 
anterior, and the anterior fibres of serratus anterior. The surgical dissection of the extended 
lateral pocket creation needs to be carefully undertaken as the fascial layer between the two 
muscles can be very thin.  
5.3.4 Partial musculo-facial cover 
Partial musculo-facial cover of the implant pocket is described, and is a simpler dissection. 
Advocates argue that placing the expander or implant in the subpectoral space alone allows 
for quicker operative time, less painful surgery, less discomfort after surgery (including 
during expansion) and better definition of the inframammary fold. The pectoralis major 
muscle is dissected free at its lateral border. The muscle is elevated and detached inferiorly 
at its insertion. Medially the dissection is carried to the parasternal region, but the muscle 
should not be detached from sternum. In particular, it is important not to detach the muscle 
along the sternal border superiorly, which would result in substantial dislocation of the 
muscle. The free inferior pectoralis major muscle should be tacked down to the lower 
mastectomy skin flap or to the inferior mammary crease as guide ropes as the muscle would 
otherwise retract resulting in poor implant cover. Spear et al. have found that placement of 
the implant partially under the mastectomy flap delivers predictable and cosmetically 
pleasing outcomes (Spear, 2004). This approach creates a breast that may be more easily 
placed on the chest wall and is unrestricted by the lower attachment of the pectoralis major 
to the rib cage. By avoiding disruption of the serratus anterior and rectus fascia, there is less 
postoperative pain as well as less pain during expansion. Because implant cover inferiorly is 
simply by the lower mastectomy flap, lower pole rippling can be more evident. It is 
important to minimize undermining of the inframammary fold and preserve adequate 
thickness of the lower mastectomy flap when possible.  
5.3.5 Acellular dermal matrix 
If an acellular dermal matrix sheet is to be used in the reconstruction, the dissection and 
creation of the submuscular pocket is simplified. The pectoralis major is freed at its lateral 
and inferior border, maintaining the attachment at the lower sternum. The selected acellular 
dermal matrix sheet is cut to size and the sheet sutured to interposition the area required to 
bridge the gap between the lower free muscle border and the inframammary crease. When 
placed in contact with viable tissue, the acellular matrix can become repopulated with 
circulating stem cells that differentiate into normal stromal components (endothelial cells, 
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fibroblasts etc), resulting in the turnover of matrix components and the integration of the 
matrix into host beds (Buinewicz, 2003; Menon, 2003). It is available in a range of sizes and 
thickness (1-16cm length, 1-6cm width and 0.18 to more than 1.8mm in thickness). The 
matrix is fairly pliable while maintaining good tensile strength. In the short term, the matrix 
acts as a barrier, adding a layer of protection under compromised skin flaps. 
Examples of acellular dermal matrices available include AlloDerm (Lifecell, Branchburg, NJ) 
and Strattice (Lifecell, Branchburg, NJ). AlloDerm is an acellular dermal matrix derived 
from human cadaver skin that has been processed and sterilized to remove all cells and 
antigenic components leaving an extracellular matrix of collagen, elastin, hyaluronic acid, 
fibronectin, proteoglycans and vascular channels. AlloDerm requires to be rehydrated 
before use for 5 minutes in sterile normal saline or Ringer’s lactate. Strattice is derived from 
pig skin and is maintained in a rehydrated state in the packaging. The Strattice sheet needs 
to be washed thoroughly in sterile saline before use to minimise patient contact with the 
preservation fluid. The combined arc length of the IMF and lateral fold is measured to 
determine the length of matrix needed. A fixed volume implant can often be used to create a 
planned one stage breast reconstruction. Expandable implants can also be used but it is 
unlikely that the acellular matrix itself enables post-operative expansion. Early expansion as 
an outpatient, however, facilitates expansion of the pocket as a whole and has been 
successfully used by the authors.  
 
Fig. 7. (clockwise from top left): A, Strattice wash. B, Strattice cut to size. C, The superior 
pocket is being closed. D, Strattice sewn in with implant in pocket  
5.3.6 Recreating the inframammary fold 
The inframammary fold may need to be recreated by suturing the dermis or superficial 
fascia back down to the chest wall. A similar manoeuvre may be required to create the 
lateral breast fold by reattaching the advanced lateral skin flaps to the chest wall, which will 
prevent the tissue expander form sliding laterally or into the axilla.  
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5.4 Device placement and intraoperative filling 
The key to successful implant reconstruction is the creation of a well-placed and adequate 
pocket. When a definitive fixed volume implant is planned in the immediate or delayed 
setting, sizers may be used intra-operatively to guide the final implant choice and position.  
Expandable implants such as the Becker series (Mentor) and the Style 150 (Allergan) are 
designed to allow post-operative inflation. Inflation of the device creates projection on the 
footprint of the implant and allows correction of small volume discrepancies and projection 
compared with the contralateral breast. Expandable implants should not be used as tissue 
expanders as the tension they exert if expected to perform as expanders often are inadequate 
or result in implant distortion, filling at sites where expansion is easier, such as the upper 
pole. Expandable implants can be placed through minimal access incisions partly inflated 
with sterile saline and inflation completed when the device is secured in its final position 
within the pocket. Optimum fill is often 75% of the saline fill or more at the time of surgery 
and only a few post-operative inflations are generally required to achieve the desired final 
size (Gui, 2003). If expandable implants with remote ports are being used, the ports need to 
be sited and secured in an accessible subcutaneous position that does not interfere with 
underclothes. The lateral chest wall near the inframammary crease enables port removal 
with a well hidden scar, or alternatively placement adjacent to a scar that can be used for 
port removal such as an axillary incision avoids exposed scars when the ports are 
subsequently removed. 
If a tissue expander is being used, accurate placement of the footprint creates the desired 
projection with subsequent inflation and therefore optimises the stretching of the overlying 
pocket tissue and skin in the expansion process. The expander is usually under filled with 
the intention of post-operative expansion in outpatients. The access ports can be integral or 
remote. Some of the integral ports with larger metallic components may not be MRI 
compatible or be perceived to interfere with radiotherapy planning and delivery. Choice of 
such expanders needs to be taken with the multidisciplinary approach to breast cancer 
management in mind. 
Choice of sutures vary with surgeon preference. Absorbable sutures are commonly used to 
close the implant pocket and include PDS, Biosyn and Vicryl. Sutures to recreate the 
inframammary crease are more controversial as to whether a non-absorbable suture such as 
nylon or prolene is necessary. The important feature of recreation of the inframammary 
crease is well placed sutures to define the inframammary crease at the correct position on 
the chest wall. Even if absorbable sutures are used the healing process and the formation of 
a soft capsule often defines the final implant position including the inframammary crease. 
5.5 Post-operative expansion 
Expansion is started once pain has settled and viability of the skin flaps is assured. There are 
generally two schools of thought for tissue expansion. Those in favour of early expansion 
commence the inflation process a few days after surgery while others wait for several 
weeks. The quality of the overlying soft tissue and patient comfort are the primary 
determining factors. A 23g needle is inserted into the injection port under aseptic conditions 
in outpatients and 50 to 100 ml are injected once or twice weekly to reach the desired 
volume. Depending on the devices used, overexpansion and maintenance of this for several 
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weeks prior to volume reduction to the desired fill may help create pseudo-ptosis, remove 
skin folds and may decrease the incidence of capsular contracture. In women who require 
post-operative radiotherapy, some surgeons prefer to fully expand these patients prior to 
commencing radiation. A massaging protocol may be initiated and continued during the 
radiotherapy to minimize fibrosis.  
The expander is exchanged for a permanent implant when radiotherapy changes have 
subsided and is often at least 6 months following the completion of radiation. In women not 
requiring radiotherapy, implant exchange can be performed a short interval after final 
expansion, commonly after one month. The inflation ports for expandable implants can be 
removed when the inflation process is complete and the ports are no longer required. Different 
implant manufacturers have their own methods described for easy and effective port removal.  
5.6 Implant exchange (second stage) 
The time period during which expansion occurs is a useful interval for patients to reflect on 
the effect the breast cancer diagnosis has had, be proactive in the reconstruction process and 
to be prepared for the final appearance of their breast reconstruction. Patients have the 
choice in decision making on breast size and position, shape and texture.  
Tissue expansion is a two-stage process where the expander is exchanged for a definitive 
implant. The range of definitive fixed volume devices and the ability to return to optimise 
the implant pocket, breast form and scars at the secondary procedure has many advantages 
for better long term results. Other secondary procedures such as nipple reconstruction and 
attention to the contralateral breast for symmetry may need to be considered at the second 
or sometimes subsequent stages of the reconstruction process. Even when an expandable 
implant is placed with the intention of using it as a permanent device, secondary implant 
exchange may become necessary in a proportion of patients because of limitations in 
symmetry. This is often due to poor or differential expansion and capsule formation. One-
stage surgery is a misnomer as secondary procedures are often required that are unrelated 
to implant exchange. In the context of expandable implants, this includes removal of the 
inflation port, nipple reconstruction and attention to the contralateral breast. Implant based 
surgery is also associated with a requirement for maintenance surgery over time.  
Skin-sparing volume reducing surgery with use of the lower de-epithelialized mastectomy 
skin flap for lower pole implant cover has made planned one-stage surgery with reference to 
obviating the need to return to the implant pocket more common. The evolution of the role 
of acellular dermal matrices may influence the place of two stage surgery where planned 
implant exchange surgery has been the recommendation.  
5.7 Delayed-immediate reconstruction 
A two staged approach that bridges the immediate and delayed settings can be employed 
with the use of a temporizing implant and is suitable for a patient who desires an immediate 
breast reconstruction but is at a higher risk of requiring chest wall radiotherapy (Kronowitz, 
2010). Following skin sparing mastectomy, a saline-filled tissue expander is inserted and 
serves as an adjustable scaffold to preserve the 3-dimensional shape of the skin envelope. If 
postmastectomy radiotherapy is not necessary, the expander is exchanged for a permanent 
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implant, either early to avoid delaying adjuvant therapy or upon completion of 
chemotherapy, to preserve the ptosis in the skin envelope. If radiotherapy is required, the 
expander is usually maintained at a constant volume to facilitate radiotherapy planning and 
delivery. Some surgeons and radiation oncologists recommend deflation of the expander 
before radiotherapy is commenced. The resultant flat chest wall facilitates delivery of 3-
beam radiotherapy. When the breast skin has recovered from the radiotherapy, a period of 
at least three if not six months, a skin preserving delayed reconstruction is performed by 
removal of the expander and transfer of an autologous tissue flap. Sometimes, the quality of 
the skin may have recovered adequately post-radiotherapy to consider further implant 
based options. The pocket may need to be optimized by fat transfer procedures prior to the 
implant exchange. 
5.8 Delayed reconstruction 
A delayed reconstruction usually requires the placement of a tissue expander to stretch the 
pre-existing mastectomy flaps. Delayed insertion of a tissue expander is usually a safe 
procedure when good quality soft tissue is available, with a reduced risk of mastectomy skin 
flap ischaemia, and wound healing complications. Delayed reconstruction also eliminates 
the uncertainty of unplanned postoperative adjuvant radiotherapy affecting a definitive 
reconstruction and allows more flexibility with scheduling. Delayed reconstruction however 
leaves patients temporarily at least without a breast mound, is usually associated with 
longer scars that may not be optimal and loss of skin. Tissue expansion to create a pocket 
must take into account whether the expansion will create sufficient skin stretch to match the 
contralateral side and what adjustments if necessary to both sides may become necessary to 
achieve symmetry. 
Preoperative markings are performed with the patient in an upright position. The 
contralateral breast inframammary crease is outlined and the transverse base diameter and 
vertical base height is measured. A template may be used to transfer these measurements in 
the mastectomy side. 
Intraoperatively, a varying length of the existing mastectomy incision is reopened for 
adequate access. The inferior lateral border of the pectoralis major muscle is identified and a 
subpectoral dissection initiated. Meticulous haemostasis is performed. Dissection beneath 
the pectoralis major muscle continues superiorly to the extent of the preoperative markings 
but not beyond to limit unwanted superior expansion and to direct expansion inferiorly. 
The submuscular dissection continues medially and inferiorly partially dividing the origin 
of the pectoralis major muscle along the parasternal border from the second rib to the fourth 
rib. This partial release of the muscle improves anterior projection and cleavage definition 
during expansion. Inferiorly the pocket dissection switches to the subcutaneous plane just 
above the serratus anterior, external oblique and rectus abdominis fascia. This dissection 
continues to the level of the marked inframammary crease. Complete release of any 
restricting scar or fascia extending nearly to the dermis at the desired IMF location will aid 
in the passive creation of a distinct fold during the expansion process. The subcutaneous 
positioning of the inferior portion of the expander is reliably safe in a delayed reconstruction 
because flap ischemia is not usually a concern. This subcutaneous placement allows easy 
expansion with improved projection in the inferior pole. 
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An appropriate expander is selected and any air within the device removed. Precise 
placement of the expander stretches the required soft tissue without unnecessary 
overexpansion. The expander is then partially filled with some saline so that the inferior 
border of the device rests at the level of the desired inframammary crease height. A drain is 
then placed in the pocket before closure of the mastectomy incision in layers. The expander 
may then be further filled to the maximum volume the soft tissues will allow.  
 
Fig. 8. Postoperative appearances followed delayed breast reconstruction following tissue 
expansion and implant exchange. Radiotherapy related skin changes are still visible. 
Expansion can commence early, and often within a few weeks if there are no concerns with 
wound healing or skin flap health. Saline is added to the expander to reach the end point of 
moderate soft tissue tension. This should result in minimal patient discomfort if any. 
Expansion continues every 2 to 4 weeks until the desired maximum point of lower pole 
projection is obtained. The final volume within the expander should closely match the size 
of the opposite breast, limiting overexpansion to 10-15%. Once full expansion has been 
achieved, the expander should remain in place for at least one month. This allows time to 
achieve a mature, pliable capsule. This period of maximum expansion also prevents any 
recoil of the soft tissue envelop once the expander is removed. The second stage involves 
exchanging the expander for a permanent implant using techniques previously described 
for the second stage of immediate reconstructions. 
6. Implant reconstruction in the irradiated breast 
Radiation has significant negative effects on all types of breast reconstruction but this effect 
is most marked in implant based reconstructions. Irradiated tissues fibrose and contract 
with time, causing an apparent increasing hardness (capsular contracture) of the implant 
based reconstruction. Patients who present with advanced diseases or with heavily involved 
axillary nodes may require chest wall radiotherapy following mastectomy so are therefore 
less favourable candidates for implant reconstructions. Several studies have shown capsular 
formation rates of between 11 to 68% with varying lengths of follow-up. 
Previous chest wall radiation is a relative contraindication to tissue expansion as a delayed 
procedure. Depending on the timing technique and quantity of radiation administered, the 
soft tissues can be unyielding. Expansion under these circumstances is therefore difficult 
with an increased risk of complications.  
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Table 3. Studies evaluating capsule formation after radiotherapy in implant IBR 
A study from the Royal Marsden Hospital found capsule formation in 38.6% of reconstructed 
breasts using a permanent expander implant followed by radiotherapy compared to 14.1% of 
reconstructed breasts not needing post mastectomy radiotherapy at a median follow-up of 4 
years (Behranwala, 2006). At univariate analysis, radiotherapy emerged as the only variable 
related to capsule formation (p<0.001) with significantly shorter time to capsule formation in 
immediate breast reconstructions that received post mastectomy radiotherapy. These results 
clearly demonstrate the relationship between radiotherapy post immediate implant breast 
reconstruction and capsular formation. However, as more than 60% of patients do not get 
capsules despite radiotherapy at 4 years, the use of implant assisted tissue expansion 
techniques still presents a viable reconstructive option in selected cases. 
 
Fig. 9. Implant assisted LD reconstruction A. before post mastectomy chest wall 
radiotherapy. B, after post mastectomy chest wall radiotherapy.  
7. Potential complications of implant based reconstructions 
7.1 Rupture 
Rupture of silicone filled implants presents two main areas of concern: release of silicone gel 
into the body and failure of the device. While there is no correlation between connective 
tissue disease and breast implants, a local inflammatory response to a silicone leak can result 
in the formation of silicone granulomas. These present as discrete breast or axillary node 
masses and can be mistaken for recurrence. 
The rates of implant rupture range from 11 to 77% depending on the study design, 
generation of implant used and the age of the implant at time of study. Grouping of all 
devices to provide a single rupture rate is also not an accurate estimation of rupture rates 
which depend on type of implant where variables include shell thickness, elastomer type, 
surface texture and shape. True implant rupture rates are associated with time from 
implantation, particularly in the case of earlier generation devices which are associated with 
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a higher rupture rate. Almost all studies have a self-selection bias of patients who present 
with signs consistent with implant rupture. Devices were subsequently examined for 
rupture and we would therefore expect a higher rate of rupture when compared to the 
general implant population. Most studies have used radiologic imaging to determine device 
integrity where overall accuracy may be limited by sensitivity or specificity. MRI imaging 
for instance has a high false positive rate of rupture. Allergan is conducting a 10 year Core 
study to assess the safety and effectiveness of their rounded implants in 715 patients. The 
rate of rupture is compared between patients undergoing scheduled MRIs at  years 1,3,5,7 
and 9 years (to screen for silent ruptures) and those not scheduled for routine MRI 
assessments. The 4 year results have now been reported and show an implant rupture rate 
of 2.7% in the MRI cohort group compared to a 0.4% rupture rate in augmented patients in 
the non-MRI cohort. No ruptures were reported in the 98 patients who had undergone 
primary implant breast reconstruction in the 4 year time period (Inamed, 2005).  
 
Table 4. Complications from implant reconstructions, comparison of published reports 
(modified from Gui, 2003) 
7.2 Infection 
The most serious threat to an implant based breast reconstruction is infection. The reported 
incidence is between 2% and 9.6%(see table 4). The first signs and symptoms may appear as 
early as 5 days or as late as 5 weeks after surgery. Commonly infections with staphylococcus 
aureus, staphylococcus epidermidis or pseudomonas appear within 5 to 7 days with 
dramatic symptoms suggestive of abscess formation. Diffuse redness, swelling, tenderness 
and systemic symptoms of fever and malaise are common. Attainment of culture material is 
helpful and intravenous antibiotics with hospital surveillance is recommended. If no 
improvement or worsening symptoms, immediate exploration is indicated in an attempt to 
downstage or control the process. In the presence of gross pus and inflammation at 
exploration, it is probably best to remove the implant, debride clearly infected tissues, 
thoroughly lavage the pocket, place a drain, and close the wound and cover with antibiotics. 
If the operative findings are favourable, it may be possible to salvage or exchange the 
implant after adequate cleaning of the pocket. Adequate soft tissue cover is essential with 
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close surveillance and appropriate antibiotic cover, guided by microbiology culture and 
sensitivity. If salvage strategies fail, the device needs to be removed and further 
reconstructive attempts delayed for a reasonable period for tissue to recover, usually at least 
6 months. Mycobacterium infection may present differently and may be suspected following 
repeated negative cultures. Signs and symptoms may be delayed for 3-5 weeks after surgery 
and are mostly local and minor, often consisting of a clear discharge from the incision with 
no systemic symptoms.  
7.3 Capsular contracture 
Symptomatic capsular contracture occurs in 3 to 5% of patients (Mandrekas 1995). Retaining 
the filling port permanently allows some surgeons to treat early signs by over inflation of 
the implant at the onset of symptoms and maintaining the over expanded state for 2 to 3 
months, followed by a return to the recommended fill range. As capsular contracture 
progresses, pocket revision may become necessary. Modest capsule formation may be 
treated by capsulotomy but often the implant capsule is thick and may need to be excised by 
capsulectomy. If soft tissue coverage is inadequate, consideration needs to be made as to 
whether this could be improved by increasing the subcutaneous adiposity by fat transfer, 
implant cover by incorporation of an acellular dermal matrix or autologous tissue such as 
using a latissimus flap. In cases of recurrent capsule formation, especially early or after 
radiotherapy, an autologous component for implant cover may become necessary or an 
elective strategic change to autologous reconstruction without implant would avoid further 
capsule related complications.  
 
Fig. 10. Grade 4 capsule contracture 
7.4 Scalloping and rippling 
Over or under filling of the device may cause visible and palpable wrinkling of the outer 
envelope. This becomes even more obvious when thin, loose or irradiated soft tissue fail to 
provide adequate padding. Irregular visible or palpable implant edges mostly in the upper 
inner quadrant of the reconstructed breast may be avoided by conforming to the saline fill 
range recommended by the manufacturer. Another site at which rippling may be more 
prominent is the inferior pole of the reconstructed breast in a dual plane approach where the 
pectoralis major covers the upper pole of the implant while the lower pole lies in the 
subcutaneous plane. 
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Textured surfaces that provide tissue ingrowth also result in tissue adhesion to the anterior 
implant pocket. The resultant tethering may contribute to visible and palpable wrinkling of 
the tissue overlying the implant. A loose pocket or a smooth surface on the other hand does 
not eliminate this problem as elasticity of the overlying skin may similarly result in a 
wrinkled appearance. Other solutions that could be considered include skin tightening, fat 
transfer, internal capsulorrhapy, incorporation of an acellular dermal matrix or the addition 
of a latissimus dorsi muscle flap. 
 
Fig. 11. Left upper pole rippling following nipple sparing mastectomy 
7.5 Skin and nipple ischaemia and necrosis 
Compromise to the blood supply of the mastectomy skin flaps or to a preserved nipple can 
result in tissue ischaemia and necrosis. The risk of skin and nipple ischaemia is elevated 
when skin sparing techniques have been used because of the increased length of the 
mastectomy flaps from the perforating blood vessels supplying the skin. Care must be taken 
to ensure that the flaps are not compromised. Supportive measures in the immediate post-
operative period such as warming (with a warming blanket and warmed intravenous 
fluids), nursing in a supine position, correction of profound anaemia and avoidance of 
hypotension may reduce the incidence of skin and nipple ischaemia. Superficial necrosis 
may be managed conservatively with supportive measures in the first instance and then 
with appropriate dressing and wound care. Infection, inflammation and skin necrosis 
should be aggressively treated either with antibiotics or excision of the necrotic skin with 
primary closure. It is particularly important to excise and repair any necrotic skin early as if 
necrotic tissue is left for longer, the risk of a wound infection increases significantly.  
 
Fig. 12. A,partial nipple necrosis following nipple sparing mastectomy. B, Close-up view of 
nipple-areolar complex showing recovery of necrotic areas 
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8. Conclusion 
Implant based breast reconstruction remains the most common method utilized to 
reconstruct a breast after mastectomy for cancer. Implant reconstruction has advanced 
through the years with better devices and improved surgical techniques. Skin-sparing 
volume reducing procedures that utilize de-epithelialized skin for implant cover have 
broadened the scope of patients suitable for implant based breast reconstruction beyond the 
traditional concept of slim to moderately built women with modest breast size and minimal 
ptosis. The further development of acellular dermal matrices and fat transfer techniques will 
see further evolution of patients suitable for implant based techniques.  
Autologous breast reconstruction is an option for many women. The choice of breast 
reconstruction depends on multiple factors when selecting the best reconstruction option for 
a patient. One consideration is the level of patient motivation and the patient’s willingness 
to undergo complex or extensive procedures, including the risk of failure or comorbidities 
associated with those procedures. The magnitude of surgery, the length of recovery, 
potential complications, resultant extensive scarring, and potential functional loss associated 
with some forms of autologous breast reconstruction may be a valid reason why patients 
opt for implant based surgery, recognising that maintenance surgery is more likely. Breast 
reconstruction using expanders and implants offers an excellent opportunity to achieve high 
quality results in breast reconstruction.  
Breast reconstruction should be tailored to meet the individual needs of patients. The 
options available and the decision making process should be fully discussed and a balance 
of benefits and risks used in the final analysis of patient choice. Units that offer breast 
reconstruction should have access to the range of options in current practice to meet these 
needs.  
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